Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch ...
Advances in controls and networks combined with components that pack more punch have opened the door to more-precise, durable, and economical pneumatic systems. Miniature CTS diaphragm pumps and ...
The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and ...
Hematology analyzers have revolutionised clinical diagnostics by automating the complete blood count (CBC) and cell differentiation processes. These instruments integrate advanced optical, electrical, ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "Blood Lead Analyzer Market Outlook 2025-2034: Market Share, and Growth Analysis By Application (Clinical Laboratories, Environmental Testing, Industrial ...
Once outside the body, stored blood begins degrading until, by day 42, they're no longer usable. Until now, assessing its quality has required laborious microscopic examination by human experts. A new ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results